Latanoprost Pharmabide

Latanoprost, the active ingredient in Latanoprost Pharmabide, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It treats open‑angle glaucoma and ocular hypertension by lowering intraocular pressure, helping to prevent optic nerve damage in affected patients. Latanoprost Pharmabide is indicated for individuals with elevated eye pressure who require long‑term pressure control.

GNH USA supplies Latanoprost Pharmabide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Latanoprost is a prostaglandin analog used to manage conditions characterized by elevated intraocular pressure. - Open-angle glaucoma: reduces intraocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent development of glaucoma. - Secondary open-angle glaucoma: decreases pressure to protect the optic nerve in secondary forms of the disease.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual pigmentation change. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Macular edema: fluid accumulation in the central retina. - Paradoxical increase in intraocular pressure. - Corneal edema: swelling of the cornea. - Ocular infection: signs of bacterial or fungal involvement.

Before initiating therapy, consider the following precautions. - Monitor intraocular pressure: regular measurements after starting treatment. - Assess for ocular infections: avoid use if active infection is present. - Avoid concurrent prostaglandin analogs: may increase pigmentary changes. - Use with caution in patients with a history of uveitis. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ophthalmic agents.

Major Interactions (Avoid): - Concomitant use of other prostaglandin analogs: additive pigmentary effects. - Non‑steroidal anti‑inflammatory eye drops: may reduce efficacy. - Systemic carbonic anhydrase inhibitors: may blunt pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure reduction. - Corticosteroid eye drops: may counteract pressure reduction.